Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
13-mediated LATS1 down-regulation contributes to epithelial-mesenchymal transition in ovarian cancer.
Yagi H, Onoyama I, Asanoma K, Hori E, Yasunaga M, Kodama K, Kijima M, Ohgami T, Kaneki E, Okugawa K, Yahata H, Kato K. Yagi H, et al. Among authors: yahata h. FASEB J. 2019 Dec;33(12):13683-13694. doi: 10.1096/fj.201901278R. Epub 2019 Sep 28. FASEB J. 2019. PMID: 31569999
Our findings uncover novel mechanisms through which Galpha(13) activation induces dysregulation of the Hippo signaling pathway, which leads to aggressive cancer phenotypes, and thereby identify a potential target for preventing the metastatic spread of OvCa.-Yagi, H., Onoy …
Our findings uncover novel mechanisms through which Galpha(13) activation induces dysregulation of the Hippo signaling pathway, which leads …
Uterine myxoid leiomyosarcoma with tumor embolism extending into the right atrium.
Imai H, Yagi H, Okugawa K, Kenjo H, Ohgami T, Kawano Y, Kaneki E, Ichinoe A, Asanoma K, Yahata H, Sonoda K, Kobayashi H, Kaku T, Kato K. Imai H, et al. Among authors: yahata h. Case Rep Obstet Gynecol. 2015;2015:316262. doi: 10.1155/2015/316262. Epub 2015 Feb 2. Case Rep Obstet Gynecol. 2015. PMID: 25722901 Free PMC article.
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.
Yahata H, Kobayashi H, Sonoda K, Shimokawa M, Ohgami T, Saito T, Ogawa S, Sakai K, Ichinoe A, Ueoka Y, Hasuo Y, Nishida M, Masuda S, Kato K. Yahata H, et al. Int J Clin Oncol. 2016 Jun;21(3):491-7. doi: 10.1007/s10147-015-0928-y. Epub 2015 Dec 10. Int J Clin Oncol. 2016. PMID: 26662632 Clinical Trial.
150 results